Mavacamten to Aficamten Transition in Patients With Obstructive Hypertrophic Cardiomyopathy
Mavacamten to Aficamten Transition in Patients With Obstructive Hypertrophic Cardiomyopathy
Recruiting · NCT07600177 · Registry updated 2026-05-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Mavacamten to Aficamten Transition in Patients With Obstructive Hypertrophic Cardiomyopathy | aortic valve disorder, aortic valve stenosis, cardiomyopathy, cardiovascular disorder, heart disorder, heart valve disorder, hypertrophic cardiomyopathy, subvalvular aortic stenosis | Recruiting | Phase 4 | 2026-05-20 | NCT07600177 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Cytokinetics | 7 |
| Oregon Health and Science University | 244 |
| Saint Lukes Hospital Mid America Heart Institute | 1 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Oregon Health & Science University | Portland | United States | 261 |
| St. Luke's Hospital - Mid America Heart Institute | Kansas City | United States | 1 |